CL2021002849A1 - Expansión ex-vivo de células t reguladoras humanas libre de perlas - Google Patents
Expansión ex-vivo de células t reguladoras humanas libre de perlasInfo
- Publication number
- CL2021002849A1 CL2021002849A1 CL2021002849A CL2021002849A CL2021002849A1 CL 2021002849 A1 CL2021002849 A1 CL 2021002849A1 CL 2021002849 A CL2021002849 A CL 2021002849A CL 2021002849 A CL2021002849 A CL 2021002849A CL 2021002849 A1 CL2021002849 A1 CL 2021002849A1
- Authority
- CL
- Chile
- Prior art keywords
- cells
- bead
- vivo expansion
- free human
- human regulatory
- Prior art date
Links
- 210000003289 regulatory T cell Anatomy 0.000 title abstract 5
- 238000011467 adoptive cell therapy Methods 0.000 abstract 1
- 238000013459 approach Methods 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0637—Immunosuppressive T lymphocytes, e.g. regulatory T cells or Treg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2301—Interleukin-1 (IL-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/51—B7 molecules, e.g. CD80, CD86, CD28 (ligand), CD152 (ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente divulgación se refiere en general a la fabricación de células T reguladoras (Tregs) para uso en la terapia celular adoptiva. En particular, la presente divulgación se refiere a enfoques simplificados para la expansión de Tregs ex vivo. Las Tregs producidas de esta manera son adecuadas para su uso en varios regímenes de inmunoterapia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962841215P | 2019-04-30 | 2019-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2021002849A1 true CL2021002849A1 (es) | 2022-11-25 |
Family
ID=73029279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2021002849A CL2021002849A1 (es) | 2019-04-30 | 2021-10-29 | Expansión ex-vivo de células t reguladoras humanas libre de perlas |
Country Status (13)
Country | Link |
---|---|
US (1) | US20220204931A1 (es) |
EP (1) | EP3963053A4 (es) |
JP (1) | JP2022530768A (es) |
KR (1) | KR20210149201A (es) |
CN (1) | CN114008192A (es) |
AU (1) | AU2020266599A1 (es) |
BR (1) | BR112021021528A2 (es) |
CA (1) | CA3137456A1 (es) |
CL (1) | CL2021002849A1 (es) |
IL (1) | IL287618A (es) |
MX (1) | MX2021013227A (es) |
SG (1) | SG11202111863RA (es) |
WO (1) | WO2020223568A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023095802A1 (ja) * | 2021-11-24 | 2023-06-01 | レグセル株式会社 | T細胞関連疾患を治療または予防するための医薬組成物 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014201846B2 (en) * | 2007-01-30 | 2016-07-07 | Epivax, Inc. | Regulatory t cell epitopes, compositions and uses thereof |
WO2012018930A1 (en) * | 2010-08-03 | 2012-02-09 | University Of Miami | Methods of isolating and expanding human t regulatory cells and uses thereof for cellular therapy |
US9481866B2 (en) * | 2011-12-16 | 2016-11-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of producing T cell populations enriched for stable regulatory T-cells |
CA2866116C (en) * | 2012-03-02 | 2021-06-15 | The Regents Of The University Of California | Expansion of alloantigen-reactive regulatory t cells |
EP2660250B1 (en) * | 2012-05-02 | 2018-11-14 | Deutsches Rheuma-Forschungszentrum Berlin | Tcr transgenic mouse model for immune disease |
PL218400B1 (pl) * | 2012-06-06 | 2014-11-28 | Gdański Univ Medyczny | Szczepionka do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnażania komórek Treg in vitro do wytwarzania szczepionki do leczenia cukrzycy typu 1 |
WO2014165581A1 (en) * | 2013-04-02 | 2014-10-09 | New York University | Gpr15-mediated homing and uses thereof |
EP3157563A1 (en) * | 2014-06-23 | 2017-04-26 | TheraMAB LLC | Compositions and methods for safe and effective immunotherapy |
US11022615B2 (en) * | 2015-05-04 | 2021-06-01 | University Of Florida Research Foundation, Inc. | Regulatory T-cells, method for their isolation and uses |
CN108291203A (zh) * | 2015-09-07 | 2018-07-17 | 国家健康科学研究所 | Cd8+cd45rc低treg的新亚群及其用途 |
-
2020
- 2020-04-30 EP EP20798975.7A patent/EP3963053A4/en active Pending
- 2020-04-30 JP JP2021563598A patent/JP2022530768A/ja active Pending
- 2020-04-30 AU AU2020266599A patent/AU2020266599A1/en active Pending
- 2020-04-30 US US17/607,354 patent/US20220204931A1/en active Pending
- 2020-04-30 WO PCT/US2020/030869 patent/WO2020223568A1/en unknown
- 2020-04-30 CA CA3137456A patent/CA3137456A1/en active Pending
- 2020-04-30 SG SG11202111863RA patent/SG11202111863RA/en unknown
- 2020-04-30 MX MX2021013227A patent/MX2021013227A/es unknown
- 2020-04-30 KR KR1020217038500A patent/KR20210149201A/ko active Search and Examination
- 2020-04-30 BR BR112021021528A patent/BR112021021528A2/pt unknown
- 2020-04-30 CN CN202080044101.2A patent/CN114008192A/zh active Pending
-
2021
- 2021-10-27 IL IL287618A patent/IL287618A/en unknown
- 2021-10-29 CL CL2021002849A patent/CL2021002849A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX2021013227A (es) | 2022-01-06 |
JP2022530768A (ja) | 2022-07-01 |
SG11202111863RA (en) | 2021-11-29 |
EP3963053A4 (en) | 2023-01-18 |
IL287618A (en) | 2021-12-01 |
CA3137456A1 (en) | 2020-11-05 |
CN114008192A (zh) | 2022-02-01 |
EP3963053A1 (en) | 2022-03-09 |
US20220204931A1 (en) | 2022-06-30 |
WO2020223568A1 (en) | 2020-11-05 |
KR20210149201A (ko) | 2021-12-08 |
BR112021021528A2 (pt) | 2022-04-19 |
AU2020266599A1 (en) | 2021-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121799T1 (el) | Παραγωγα πυριμιδο[4,5-β]ινδολης και χρηση εξ αυτων στην επεκταση των αιμοποιητικων αρχεγονων κυτταρων | |
CY1125092T1 (el) | Ιατρικη χρηση σχετικα με επεκταση τελομερους | |
MX2020004240A (es) | Proceso para generar composiciones terapeuticas de celulas modificadas. | |
BR112015017174A2 (pt) | preparação de enxertos de nervo de tecido manipulado com matriz extracelular modificada para reparo de lesão de nervo periférico | |
BR112015030972A8 (pt) | células sc-beta e composições e métodos para geração das mesmas | |
UY31830A (es) | Activadores de glucoquinasa | |
BR112022002955A2 (pt) | Células imunes para terapias de células adotivas | |
CL2021002770A1 (es) | Compuestos de 4h-pirrolo[3,2-c]piridin-4-ona | |
TWD201825S (zh) | 太陽能電池 | |
BR112015021993A2 (pt) | composições de cultura celular com antioxidantes e métodos para produção de polipeptídeo | |
BR112021019349A2 (pt) | Células-tronco preparadas altamente funcionais | |
CO2022000481A2 (es) | Inhibidores de enzimas | |
CO2021007657A2 (es) | Métodos para expansión ex vivo de células asesinas naturales y uso de los mismos | |
UY38797A (es) | Anticuerpos inmunomoduladores y métodos de uso de los mismos | |
MX2020004939A (es) | Fabricacion de composiciones de celulas islote y metodos de uso de las mismas. | |
CL2021002849A1 (es) | Expansión ex-vivo de células t reguladoras humanas libre de perlas | |
BR112022001416A2 (pt) | Populações de células t gama delta ex vivo | |
MX2021011608A (es) | Metodos ex vivo para producir celulas t terapeuticas y composiciones y metodos afines. | |
CL2010000774A1 (es) | Medio para el cultivo de celulas de mamiferos que comprende ademas de los nutrientes habituales de los medios de cultivo basales para cultivo de celulas de mamiferos, sobrenadante de la fraccion ii+iii del plasma humano segun el metodo de cohn; procedimiento de preparacion; y su uso. | |
MX2021002702A (es) | Metodos para expandir celulas t del receptor de antigeno quimerico especificas de antigenos, composiciones y usos relacionados con las mismas. | |
AR120475A1 (es) | Producción de células precursoras hematopoyéticas | |
EP4235175A3 (en) | Methods for culturing human keratinocytes | |
CL2011001870A1 (es) | Proceso de preparacion de un gel de fibrina autologo o desde sangre compatible para proliferacion y vehiculizacion celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirurgico. | |
MX2020004239A (es) | Proceso para producir una composicion de celulas t. | |
CY1121240T1 (el) | Συνθεση και μεθοδος για τη δημιουργια επιθυμητου τυπου κυτταρων και/ή τυπου ιστου απο βλαστικα κυτταρα θυλακα τριχας |